Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

M&A Analysis: October Notches 30 Deals In Big M&A Boom

The medtech M&A deal count soared in October with a total of 30 deals announced and closed in the month. It was an especially busy month for the orthopedics sector, with a number of high profile deals inked.

M & A Deals

Tissue Regenix Completes Search For New CEO

Regenerative medicine firm Tissue Regenix has named Steve Couldwell as its new CEO, following the departure of Anthony Odell, who led the group for over a decade.

Appointments Regenerative Medicine

Cambridge Epigenetix Boosts Senior Leadership Team With New Hires

Cambridge Epigenetix Ltd. (CEGX) has appointed two new senior executives to help drive development of its epigenetics-based diagnostic technologies. Hayden Jeffreys joins the company as COO and Joanne Mason as vice president of biomarker discovery.

Diagnostics Appointments

genedrive Severs Ties With India Distributor Xcelris Labs

Molecular diagnostics company genedrive has severed ties with its India distributor Xcleris Labs following problems with its MTB/RIF test for tuberculosis.

Commercial Companies

Device Week, Nov. 2, 2017 – On M&A, Merck And Med In Ireland

In this edition of Device Week, Medtech Insight’s Tina Tan chats to Catherine Longworth about the recent surge in M&A deal-making and wonder if this would impact 2017’s overall outlook. They also chat about Merck’s ambitions to be an all-round leader in fertility treatment, for both drugs and devices and what makes Ireland continue to be an attractive medtech hub for generating innovation.

M & A Ireland

Philips' Scottish Digital Pathology Pilot Could Lead To Nationwide Deal

Philips is teaming up with NHS Glasgow & Clyde and NHS Lothian to pilot a national digital pathology service for Scotland. The pilot will last up to 12 months and is designed to establish a digitized national pathology service across Scottish hospitals.

Digital Health Diagnostic Imaging
See All